Similar articles

• [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].

  García Pérez A, Valverde de La Osa J, Giménez Samper M, Alonso García I. García Pérez A, et al. Sangre (Barc). 1999 Oct;44(5):387-8. Sangre (Barc). 1999. PMID: 10618919 Spanish. No abstract available.
• Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.

  al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. al-Assi MT, et al. Am J Gastroenterol. 1994 Aug;89(8):1203-5. Am J Gastroenterol. 1994. PMID: 8053435
• Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.

  Peura DA, Graham DY. Peura DA, et al. Am J Gastroenterol. 1994 Aug;89(8):1137-9. Am J Gastroenterol. 1994. PMID: 8053422 Review. No abstract available.
• Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.

  Taylor JL, Zagari M, Murphy K, Freston JW. Taylor JL, et al. Arch Intern Med. 1997 Jan 13;157(1):87-97. Arch Intern Med. 1997. PMID: 8996045
• Treating peptic ulcer: an ongoing challenge.

  Cohen MH. Cohen MH. J Am Osteopath Assoc. 1995 Apr;95(4):239-41. J Am Osteopath Assoc. 1995. PMID: 7744624 Review. No abstract available.